NIH Guide for the week ending June 18, 2021: funding-related notices and opportunities

Sponsor: 

National Institutes of Health

UI Contact: 

The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:

General Notices

NIA Announces New Policy and Procedures for the Reporting of Human Subjects Enrollment Data for NIA Clinical Research Trials/Studies
National Institute on Aging

 

Notice of Expiration of NOT-DA-18-017, "NIDA to Highlight Topics of Special and/or Continuing Interest in Addiction Research on the NIDA Website"
National Institute on Drug Abuse

 

Notice of Informational Webinar on the Intramural NIGMS Postdoctoral Research Associate Training (PRAT) Program and Fi2 Application Process
National Institute of General Medical Sciences

 

Notice of Pre-Application Webinars for the High-Risk, High-Reward Research Program's Pioneer (RFA-RM-21-015), New Innovator (RFA-RM-21-016), Transformative Research (RFA-RM-21-017), and Early Independence (RFA-RM-21-018) Awards
Office of Strategic Coordination (Common Fund)

 

Request for Information (RFI): Inviting Input on NIAAAs 2022-2026 Strategic Plan Outline
National Institute on Alcohol Abuse and Alcoholism

 

Request for Information (RFI): Input for National Cancer Institute (NCI) Pediatric Immunotherapy Network
National Cancer Institute

 

Request for Information (RFI) on Datasets Collecting Temporally-Linked Diet, Physical Activity, and Sleep Data to Facilitate Integrated Research on 24-Hour Behavior Patterns
National Cancer Institute

 

Notice of Changes to Funding Opportunities

Notice of Change to Key Dates for PAR-21-157 The Midlife in the United States Study - Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed)
National Institute on Aging

 

Notice of Change to Key Dates and Application Types Allowed for PAR-21-156 The Midlife in the United States Study (U19 Clinical Trial Not Allowed)
National Institute on Aging

 

Notice of Participation of the National Institute on Aging (NIA) in PAR-21-230 "Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)"
National Institute on Aging

 

Notice of Modifications to PAR-21-075, "Research Experience in Genomic Research for Data Scientists (R25)"
National Human Genome Research Institute

 

Notice of Change in Key Dates and Award Information for RFA-HL-21-013 "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)"
National Heart, Lung, and Blood Institute

 

Notice of Participation of NINR in PAR-20-125, Native American Research Centers for Health (NARCH) (S06 Clinical Trials Optional)
National Institute of Nursing Research

 

Notice of Change to NOT-NR-21-001: "Notice of Special Interest (NOSI): NINR Priority Areas for Training and Career Development Awards"
National Institute of Nursing Research

 

Notices of Intent to Publish

Notice of Intent to Publish a Funding Opportunity Announcement for Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases

 

Notice of Intent to Publish a Funding Opportunity Announcement for Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)
National Cancer Institute

 

Notices of Special Interest

Notice of Special Interest (NOSI): HIV Drug Resistance Assays and Actionable Data Dissemination Strategies
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse

 

Funding Opportunities

Large Health Services Research Demonstration and Dissemination Projects for Prevention of Healthcare-Associated Infections (R18)
Agency for Healthcare Research and Quality

 

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
National Center for Complementary and Integrative Health

 

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
National Center for Complementary and Integrative Health

 

Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
National Center for Complementary and Integrative Health

 

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
National Center for Complementary and Integrative Health

 

Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Allergy and Infectious Diseases

 

Role of Adaptive Immunity in Etiology of Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional)
National Institute on Aging
National Institute of Neurological Disorders and Stroke

 

Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed)
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases

 

Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health

 

Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional)
National Institute on Drug Abuse

 

PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)
National Institute on Drug Abuse

 

Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute

 

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu  or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu  or Dave Myers at dave-myers@uiowa.edu  or Lynn Hudachek at lynn-hudachek@uiowa.edu.

Categories: